• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emmaus Life Sciences Inc


Pending Listing

Emmaus Life Sciences Inc (EMMA:US) is pending listing

Company Profile

Emmaus Holdings Inc. is engaged in the discovery, development and commercialization of treatments and therapies for rare diseases. The Company's primary focus is the late-stage development of the amino acid L-glutamine as a prescription drug for the treatment of sickle cell disease ("SCD").

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil